Why the study?
Even after optimal medical treatment, some heart failure patients remain at high risk for clinical events, highlighting the importance of identifying those at risk of death or hospitalization.
Answers are grounded in this paper and cite their sources.
This review discusses the role of systemic biomarkers, particularly natriuretic peptides, in the prognosis and risk stratification of heart failure.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Humberto Villacorta (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: